World's Best Scientists 2026 revealed!
Award Badge
Biology and Biochemistry
Australia
2023
Award Badge
Medicine
Australia
2023

D-Index & Metrics

Biology and Biochemistry

D-Index
83
Citations
39599
World Ranking
3426
National Ranking
78

Medicine

D-Index
89
Citations
42823
World Ranking
12452
National Ranking
403

David Goldstein publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where David Goldstein sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 670 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

David Goldstein D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where David Goldstein sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 83 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Biology and Biochemistry in Australia Leader Award
  • 2023 - Research.com Medicine in Australia Leader Award
  • 2022 - Research.com Biology and Biochemistry in Australia Leader Award
  • 2013 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 1994 - Fellow of American Physical Society (APS) Citation For playing a leading role in enactment of energy efficiency laws and regulations in the United States

Overview

David Goldstein is affiliated with the University of New South Wales in Australia and has an extensive research portfolio primarily within the field of Medicine. Their work addresses several subfields, including Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Public Health, Environmental and Occupational Health, and Genetics.

Their research focuses intensely on topics related to cancer, especially pancreatic and hepatic oncology. Other significant areas of study include cancer treatment and pharmacology, cancer genomics and diagnostics, chemotherapy-related skin toxicity, gastric cancer management and outcomes, cancer cells and metastasis, and multiple myeloma research and treatments.

Frequent publication venues for this scientist include the following journals:

  • Journal of Clinical Oncology
  • Supportive Care in Cancer
  • Annals of Oncology
  • Radiotherapy and Oncology
  • Pancreatology

Notable recent papers authored or co-authored by David Goldstein include:

  • "Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group" (2023, Journal of Clinical Oncology)
  • "Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition" (2021, Cancer Research)
  • "Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial" (2022, Journal of Clinical Oncology)
  • "Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy" (2021, JAMA Network Open)
  • "Targeting HGF/c-MET Axis in Pancreatic Cancer" (2020, International Journal of Molecular Sciences)

Collaboration is a significant aspect of their work, with frequent co-authors including:

  • Susanna B. Park (31 joint publications)
  • Tiffany Li (18 joint publications)
  • Hannah C. Timmins (16 joint publications)
  • Terry Trinh (16 joint publications)
  • Mandy L. Ballinger (16 joint publications)

David Goldstein has received recognition from professional organizations, including being named a Fellow of the American Association for the Advancement of Science (AAAS) in 2013. Additionally, they were awarded Fellowship of the American Physical Society (APS) in 1994, with a citation acknowledging their role in energy efficiency legislation and regulations in the United States.

Best Publications

  • Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

    Daniel D. Von Hoff;Thomas Ervin;Francis P. Arena;E. Gabriela Chiorean

  • Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial

    John P. Neoptolemos;Deborah D. Stocken;Claudio Bassi;Paula Ghaneh

  • Chemotherapy-induced peripheral neurotoxicity: a critical analysis.

    Susanna B. Park;David Goldstein;Arun V. Krishnan;Cindy S-Y Lin

  • (Open Access) Supercapacitor and supercapattery as emerging electrochemical energy stores

    Unknown

  • Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells.

    M. V. Apte;S. Park;P. A. Phillips;N. Santucci

  • nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

    David Goldstein;Robert Hassan El-Maraghi;Pascal Hammel;Volker Heinemann

  • Cancer patient preferences for communication of prognosis in the metastatic setting.

    Rebecca G. Hagerty;Phyllis N. Butow;Peter A. Ellis;Elizabeth A. Lobb

  • Pancreatic Stellate Cells: Partners in Crime with Pancreatic Cancer Cells

    Alain Vonlaufen;Swapna Joshi;Changfa Qu;Phoebe A. Phillips

  • Binary temporal upconversion codes of Mn2+-activated nanoparticles for multilevel anti-counterfeiting

    Unknown

  • Efficient image super-resolution using pixel attention

    Unknown

  • Real-Time Energy Storage Management for Renewable Integration in Microgrids: An Off-line Optimization Approach

    Unknown

  • Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study

    Juan W. Valle;Daniel Palmer;Richard Jackson;Trevor Cox

  • Role of Pancreatic Stellate Cells in Pancreatic Cancer Metastasis

    Zhihong Xu;Alain Vonlaufen;Phoebe A. Phillips;Eva Fiala-Beer

  • Fertility- and Menopause-Related Information Needs of Younger Women With a Diagnosis of Early Breast Cancer

    Belinda Thewes;B. Meiser;A. Taylor;K. A. Phillips

  • Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study

    Jeanne Tie;Joshua D Cohen;Yuxuan Wang;Lu Li

  • Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial

    William Greenhalf;Paula Ghaneh;John P. Neoptolemos;Daniel H. Palmer

  • Environmental Epidemiology, Volume 1: Public Health and Hazardous Wastes

    Unknown

  • Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer

    Desmond Yip;Christos Karapetis;Andrew Strickland;Christopher B Steer

  • QT interval variability in body surface ECG: measurement, physiological basis, and clinical value: position statement and consensus guidance endorsed by the European Heart�…

    Unknown

  • Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer.

    James F. Bishop;Joanna Dewar;Guy C. Toner;Jennifer Smith

Frequent Co-Authors

Slavé Petrovski
Slavé Petrovski AstraZeneca (United Kingdom)
Joshua A. Frieman
Joshua A. Frieman University of Chicago
Erin L. Heinzen
Erin L. Heinzen University of North Carolina at Chapel Hill
Peter Nugent
Peter Nugent Lawrence Berkeley National Laboratory
Ryan J. Foley
Ryan J. Foley University of California, Santa Cruz
Mark Sullivan
Mark Sullivan University of Southampton
Kevin V. Shianna
Kevin V. Shianna Duke University
H. M. Spinka
H. M. Spinka Argonne National Laboratory
Dongliang Ge
Dongliang Ge Apostle Diagnostics

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a degree in Biology or Biochemistry opens doors to a range of advanced online programs and diverse healthcare careers. Many students choose to further their education by pursuing specialized graduate degrees that build upon their foundational science knowledge.

For those interested in healthcare administration, cahme accredited mha programs offer the flexibility to earn a master’s degree and qualify for leadership roles in hospital and health systems management. If clinical practice is your passion but you prefer a flexible, non-traditional setting, online dnp programs may be a great fit, especially for nurses looking to advance without in-person clinicals.

Ambitious learners aiming for research or executive roles might consider a phd in healthcare management to develop expertise in health policy, leadership, and academic teaching. Meanwhile, science graduates intrigued by the pharmaceutical field can look into pharmd online programs to become licensed pharmacists.

Choosing the right online degree can empower you to build a meaningful career that blends scientific knowledge with a variety of rewarding professional paths in healthcare.

Best Scientists Citing David Goldstein

Trending Scientists

Recently Published Articles